John Carroll
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Transcatheter Aortic Valve Replacement | 53 | 2023 | 162 | 14.130 |
Why?
| Foramen Ovale, Patent | 33 | 2024 | 45 | 11.470 |
Why?
| Cardiac Catheterization | 57 | 2024 | 577 | 11.040 |
Why?
| Aortic Valve Stenosis | 45 | 2023 | 315 | 9.280 |
Why?
| Heart Valve Prosthesis Implantation | 25 | 2023 | 191 | 6.560 |
Why?
| Coronary Angiography | 31 | 2020 | 336 | 6.550 |
Why?
| Septal Occluder Device | 21 | 2021 | 48 | 6.070 |
Why?
| Heart Valve Prosthesis | 20 | 2022 | 126 | 5.410 |
Why?
| Stroke | 33 | 2024 | 1090 | 5.000 |
Why?
| Echocardiography, Transesophageal | 18 | 2021 | 92 | 5.000 |
Why?
| Echocardiography, Three-Dimensional | 12 | 2019 | 52 | 4.910 |
Why?
| Aortic Valve | 35 | 2023 | 428 | 4.240 |
Why?
| Heart Septal Defects, Atrial | 11 | 2020 | 52 | 3.850 |
Why?
| Mitral Valve | 16 | 2023 | 94 | 3.710 |
Why?
| Imaging, Three-Dimensional | 24 | 2019 | 511 | 3.650 |
Why?
| Registries | 35 | 2023 | 2020 | 3.510 |
Why?
| Mitral Valve Insufficiency | 12 | 2023 | 65 | 3.460 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 16 | 2019 | 112 | 3.350 |
Why?
| Radiography, Interventional | 13 | 2020 | 117 | 3.300 |
Why?
| Heart Valve Diseases | 14 | 2019 | 137 | 2.940 |
Why?
| Ultrasonography, Interventional | 10 | 2020 | 156 | 2.820 |
Why?
| Secondary Prevention | 13 | 2024 | 257 | 2.590 |
Why?
| Treatment Outcome | 76 | 2024 | 9692 | 2.510 |
Why?
| Echocardiography, Doppler, Color | 8 | 2019 | 38 | 2.230 |
Why?
| Embolism, Paradoxical | 7 | 2020 | 7 | 1.920 |
Why?
| Angioplasty, Balloon, Coronary | 13 | 2010 | 163 | 1.770 |
Why?
| Fluoroscopy | 10 | 2021 | 149 | 1.720 |
Why?
| Heart Defects, Congenital | 8 | 2020 | 721 | 1.720 |
Why?
| Cardiac Surgical Procedures | 8 | 2023 | 477 | 1.700 |
Why?
| Humans | 189 | 2024 | 122796 | 1.570 |
Why?
| Prosthesis Implantation | 6 | 2019 | 148 | 1.530 |
Why?
| Coronary Artery Disease | 11 | 2011 | 695 | 1.490 |
Why?
| Cardiology | 13 | 2023 | 338 | 1.410 |
Why?
| Thoracic Surgery | 10 | 2021 | 123 | 1.360 |
Why?
| Heart Diseases | 5 | 2019 | 358 | 1.330 |
Why?
| Stents | 16 | 2011 | 491 | 1.310 |
Why?
| Catheterization | 8 | 2010 | 165 | 1.310 |
Why?
| Predictive Value of Tests | 20 | 2019 | 1947 | 1.290 |
Why?
| Iatrogenic Disease | 3 | 2018 | 53 | 1.240 |
Why?
| Heart Injuries | 4 | 2018 | 39 | 1.220 |
Why?
| Coronary Vessels | 8 | 2010 | 237 | 1.210 |
Why?
| Prostheses and Implants | 6 | 2013 | 145 | 1.210 |
Why?
| Cineangiography | 7 | 2009 | 17 | 1.200 |
Why?
| Hypoxia | 4 | 2020 | 1003 | 1.180 |
Why?
| Risk Factors | 40 | 2023 | 9381 | 1.130 |
Why?
| Image Enhancement | 3 | 2013 | 185 | 1.090 |
Why?
| Societies, Medical | 9 | 2020 | 741 | 1.070 |
Why?
| Radiation Dosage | 8 | 2016 | 156 | 1.050 |
Why?
| Mitral Valve Stenosis | 4 | 2016 | 21 | 1.050 |
Why?
| Platelet Aggregation Inhibitors | 10 | 2024 | 425 | 1.040 |
Why?
| Image Processing, Computer-Assisted | 8 | 2015 | 739 | 1.040 |
Why?
| Ischemic Attack, Transient | 3 | 2015 | 64 | 1.030 |
Why?
| Aged, 80 and over | 35 | 2022 | 6845 | 1.030 |
Why?
| Aged | 60 | 2023 | 20495 | 1.020 |
Why?
| Prosthesis Failure | 5 | 2020 | 122 | 1.020 |
Why?
| Male | 90 | 2023 | 59639 | 0.990 |
Why?
| Prosthesis Design | 13 | 2019 | 293 | 0.990 |
Why?
| Coronary Stenosis | 3 | 2010 | 44 | 0.950 |
Why?
| Sodium Chloride | 2 | 2015 | 154 | 0.940 |
Why?
| Fibrinolytic Agents | 6 | 2022 | 257 | 0.920 |
Why?
| Contrast Media | 6 | 2015 | 387 | 0.910 |
Why?
| Multimodal Imaging | 3 | 2020 | 102 | 0.890 |
Why?
| Intracranial Embolism | 1 | 2022 | 27 | 0.880 |
Why?
| Female | 82 | 2023 | 63629 | 0.860 |
Why?
| Percutaneous Coronary Intervention | 2 | 2020 | 535 | 0.850 |
Why?
| United States | 42 | 2023 | 13272 | 0.840 |
Why?
| Tomography, X-Ray Computed | 9 | 2020 | 2500 | 0.840 |
Why?
| Technology Transfer | 1 | 2021 | 14 | 0.820 |
Why?
| Time Factors | 20 | 2022 | 6682 | 0.770 |
Why?
| Device Removal | 4 | 2012 | 127 | 0.770 |
Why?
| Computed Tomography Angiography | 3 | 2020 | 85 | 0.760 |
Why?
| Embolism | 3 | 2019 | 45 | 0.740 |
Why?
| Randomized Controlled Trials as Topic | 9 | 2021 | 1260 | 0.730 |
Why?
| Risk Assessment | 17 | 2021 | 3213 | 0.730 |
Why?
| Echocardiography | 9 | 2020 | 591 | 0.710 |
Why?
| Surgery, Computer-Assisted | 4 | 2009 | 71 | 0.700 |
Why?
| Postoperative Complications | 11 | 2021 | 2301 | 0.700 |
Why?
| Migraine Disorders | 4 | 2021 | 81 | 0.700 |
Why?
| Coronary Occlusion | 1 | 2019 | 20 | 0.700 |
Why?
| Lacerations | 1 | 2019 | 28 | 0.690 |
Why?
| Mitral Valve Annuloplasty | 1 | 2019 | 3 | 0.690 |
Why?
| Dyspnea | 1 | 2020 | 214 | 0.680 |
Why?
| Product Surveillance, Postmarketing | 4 | 2015 | 70 | 0.680 |
Why?
| Middle Aged | 43 | 2022 | 28563 | 0.670 |
Why?
| Shock, Cardiogenic | 1 | 2019 | 62 | 0.660 |
Why?
| Technology Assessment, Biomedical | 2 | 2015 | 29 | 0.660 |
Why?
| Balloon Occlusion | 3 | 2014 | 27 | 0.650 |
Why?
| Thrombosis | 4 | 2012 | 319 | 0.630 |
Why?
| Atrial Fibrillation | 4 | 2020 | 392 | 0.630 |
Why?
| Inferior Wall Myocardial Infarction | 1 | 2017 | 2 | 0.620 |
Why?
| Heart Rupture, Post-Infarction | 1 | 2017 | 3 | 0.620 |
Why?
| Papillary Muscles | 1 | 2017 | 16 | 0.620 |
Why?
| Patient Selection | 10 | 2019 | 717 | 0.610 |
Why?
| Models, Cardiovascular | 3 | 2008 | 183 | 0.600 |
Why?
| Radiographic Image Enhancement | 4 | 2009 | 67 | 0.580 |
Why?
| Therapy, Computer-Assisted | 2 | 2014 | 62 | 0.580 |
Why?
| Aorta | 3 | 2009 | 368 | 0.580 |
Why?
| ST Elevation Myocardial Infarction | 1 | 2017 | 60 | 0.570 |
Why?
| Surgeons | 4 | 2022 | 245 | 0.570 |
Why?
| Multidetector Computed Tomography | 1 | 2016 | 28 | 0.560 |
Why?
| Medicare | 8 | 2023 | 767 | 0.560 |
Why?
| Aortography | 1 | 2016 | 55 | 0.560 |
Why?
| Severity of Illness Index | 11 | 2021 | 2784 | 0.550 |
Why?
| Diagnostic Imaging | 3 | 2010 | 310 | 0.550 |
Why?
| Heart Ventricles | 3 | 2018 | 741 | 0.550 |
Why?
| Echocardiography, Stress | 1 | 2015 | 27 | 0.540 |
Why?
| Exercise Test | 3 | 2015 | 588 | 0.530 |
Why?
| Consensus | 9 | 2021 | 554 | 0.530 |
Why?
| Aortic Valve Insufficiency | 1 | 2015 | 45 | 0.520 |
Why?
| Fistula | 2 | 2022 | 27 | 0.510 |
Why?
| Embolization, Therapeutic | 2 | 2007 | 199 | 0.500 |
Why?
| Foreign-Body Migration | 2 | 2012 | 39 | 0.500 |
Why?
| Retrospective Studies | 21 | 2021 | 13433 | 0.490 |
Why?
| Radiation Injuries | 1 | 2015 | 137 | 0.490 |
Why?
| Heart Septal Defects, Ventricular | 3 | 2009 | 43 | 0.490 |
Why?
| Reoperation | 6 | 2021 | 570 | 0.490 |
Why?
| Heart Septal Defects | 3 | 2008 | 10 | 0.490 |
Why?
| Health Policy | 1 | 2017 | 356 | 0.480 |
Why?
| Hospital Mortality | 11 | 2021 | 901 | 0.480 |
Why?
| Balloon Valvuloplasty | 1 | 2013 | 3 | 0.470 |
Why?
| Surgical Instruments | 1 | 2012 | 51 | 0.430 |
Why?
| Incidence | 10 | 2021 | 2527 | 0.430 |
Why?
| Aortic Rupture | 1 | 2012 | 27 | 0.430 |
Why?
| Reproducibility of Results | 12 | 2021 | 2977 | 0.420 |
Why?
| Triiodobenzoic Acids | 2 | 2011 | 14 | 0.410 |
Why?
| Models, Anatomic | 2 | 2009 | 94 | 0.410 |
Why?
| Adult | 27 | 2023 | 32385 | 0.400 |
Why?
| Coronary Restenosis | 2 | 2009 | 20 | 0.400 |
Why?
| Myocardial Infarction | 8 | 2008 | 1134 | 0.400 |
Why?
| Prospective Studies | 14 | 2023 | 6704 | 0.390 |
Why?
| Sensitivity and Specificity | 7 | 2019 | 1855 | 0.390 |
Why?
| Heart Atria | 5 | 2012 | 121 | 0.390 |
Why?
| Catheter Ablation | 2 | 2018 | 324 | 0.390 |
Why?
| Angiography | 4 | 2019 | 193 | 0.380 |
Why?
| Computer Simulation | 4 | 2008 | 945 | 0.380 |
Why?
| Coronary Disease | 3 | 2009 | 372 | 0.370 |
Why?
| Equipment Design | 5 | 2014 | 533 | 0.370 |
Why?
| Follow-Up Studies | 14 | 2019 | 4768 | 0.360 |
Why?
| Coronary Thrombosis | 1 | 2009 | 27 | 0.350 |
Why?
| Angiocardiography | 1 | 2009 | 1 | 0.350 |
Why?
| Algorithms | 7 | 2010 | 1593 | 0.350 |
Why?
| Rotation | 4 | 2011 | 126 | 0.340 |
Why?
| Anticoagulants | 4 | 2021 | 589 | 0.330 |
Why?
| Myocardial Revascularization | 1 | 2009 | 84 | 0.330 |
Why?
| Evidence-Based Medicine | 4 | 2019 | 731 | 0.330 |
Why?
| Oxygen | 1 | 2013 | 887 | 0.330 |
Why?
| Clinical Decision-Making | 4 | 2019 | 293 | 0.330 |
Why?
| Survival Rate | 12 | 2021 | 1810 | 0.330 |
Why?
| Drug-Eluting Stents | 1 | 2009 | 79 | 0.330 |
Why?
| Stroke Volume | 2 | 2009 | 553 | 0.330 |
Why?
| Migraine with Aura | 1 | 2008 | 10 | 0.320 |
Why?
| Heart Septum | 1 | 2008 | 28 | 0.320 |
Why?
| Recurrence | 7 | 2022 | 998 | 0.320 |
Why?
| Echocardiography, Doppler | 1 | 2008 | 105 | 0.320 |
Why?
| Ventricular Septum | 1 | 2007 | 10 | 0.320 |
Why?
| Practice Guidelines as Topic | 5 | 2019 | 1519 | 0.310 |
Why?
| Monitoring, Intraoperative | 1 | 2007 | 43 | 0.310 |
Why?
| Patient Simulation | 1 | 2008 | 33 | 0.310 |
Why?
| Coronary Artery Bypass | 1 | 2009 | 226 | 0.300 |
Why?
| Pericardium | 1 | 2007 | 53 | 0.300 |
Why?
| Health Status | 3 | 2021 | 758 | 0.300 |
Why?
| Hemodynamics | 6 | 2020 | 1036 | 0.300 |
Why?
| Hemostatic Techniques | 1 | 2007 | 41 | 0.300 |
Why?
| Catheters, Indwelling | 1 | 2007 | 82 | 0.300 |
Why?
| Clinical Competence | 6 | 2019 | 973 | 0.290 |
Why?
| Advisory Committees | 2 | 2018 | 229 | 0.290 |
Why?
| Comprehension | 1 | 2008 | 169 | 0.280 |
Why?
| Wounds, Penetrating | 1 | 2007 | 79 | 0.280 |
Why?
| Hemorrhage | 4 | 2018 | 663 | 0.280 |
Why?
| Cohort Studies | 7 | 2023 | 5294 | 0.280 |
Why?
| Recovery of Function | 3 | 2019 | 610 | 0.270 |
Why?
| Equipment Failure | 3 | 2012 | 116 | 0.270 |
Why?
| Aortic Diseases | 1 | 2007 | 95 | 0.270 |
Why?
| Patient Readmission | 4 | 2019 | 691 | 0.270 |
Why?
| Ischemia | 1 | 2009 | 382 | 0.270 |
Why?
| Ventricular Function, Left | 1 | 2009 | 493 | 0.270 |
Why?
| Immunoglobulin Fab Fragments | 6 | 2008 | 74 | 0.270 |
Why?
| Blood Vessel Prosthesis | 1 | 2006 | 119 | 0.260 |
Why?
| Aneurysm, False | 1 | 2005 | 48 | 0.260 |
Why?
| N-Acetylmuramoyl-L-alanine Amidase | 1 | 2004 | 8 | 0.260 |
Why?
| Aortic Aneurysm | 1 | 2005 | 67 | 0.250 |
Why?
| Education, Medical | 1 | 2008 | 243 | 0.250 |
Why?
| Equipment Safety | 1 | 2004 | 42 | 0.250 |
Why?
| Healthcare Disparities | 2 | 2020 | 494 | 0.250 |
Why?
| Antibodies, Antiphospholipid | 1 | 2004 | 23 | 0.240 |
Why?
| Antiphospholipid Syndrome | 1 | 2004 | 29 | 0.240 |
Why?
| Anatomy, Cross-Sectional | 1 | 2003 | 12 | 0.230 |
Why?
| Magnetic Resonance Angiography | 1 | 2005 | 214 | 0.230 |
Why?
| Automation | 2 | 2016 | 79 | 0.220 |
Why?
| Aspirin | 3 | 2020 | 344 | 0.220 |
Why?
| Embolic Protection Devices | 1 | 2022 | 10 | 0.220 |
Why?
| Practice Patterns, Physicians' | 3 | 2019 | 1267 | 0.220 |
Why?
| Aneurysm | 1 | 2022 | 33 | 0.220 |
Why?
| Ventricular Dysfunction, Left | 1 | 2006 | 401 | 0.220 |
Why?
| Hospitals, High-Volume | 2 | 2019 | 49 | 0.210 |
Why?
| Pacemaker, Artificial | 2 | 2020 | 116 | 0.210 |
Why?
| Prognosis | 5 | 2021 | 3563 | 0.210 |
Why?
| Arteries | 1 | 2003 | 256 | 0.210 |
Why?
| Quality of Health Care | 3 | 2019 | 631 | 0.210 |
Why?
| Renal Insufficiency | 1 | 2003 | 154 | 0.200 |
Why?
| Decompression Sickness | 1 | 2021 | 2 | 0.200 |
Why?
| Cost-Benefit Analysis | 3 | 2019 | 573 | 0.200 |
Why?
| Learning Curve | 2 | 2019 | 68 | 0.200 |
Why?
| Mycobacterium tuberculosis | 1 | 2004 | 304 | 0.200 |
Why?
| Health Resources | 2 | 2019 | 136 | 0.200 |
Why?
| Observer Variation | 3 | 2011 | 314 | 0.190 |
Why?
| Minimally Invasive Surgical Procedures | 2 | 2014 | 162 | 0.190 |
Why?
| Cardiovascular Agents | 3 | 2014 | 140 | 0.190 |
Why?
| Thromboembolism | 1 | 2021 | 105 | 0.190 |
Why?
| Colorado | 4 | 2019 | 4325 | 0.180 |
Why?
| Image Interpretation, Computer-Assisted | 2 | 2015 | 229 | 0.180 |
Why?
| American Heart Association | 2 | 2019 | 313 | 0.180 |
Why?
| Databases, Factual | 3 | 2020 | 1287 | 0.180 |
Why?
| Computer Systems | 2 | 2009 | 48 | 0.180 |
Why?
| Rural Health Services | 1 | 2020 | 108 | 0.180 |
Why?
| Delivery of Health Care, Integrated | 2 | 2019 | 247 | 0.170 |
Why?
| Pattern Recognition, Automated | 3 | 2010 | 78 | 0.170 |
Why?
| Neurologists | 1 | 2019 | 19 | 0.170 |
Why?
| Multicenter Studies as Topic | 4 | 2023 | 247 | 0.170 |
Why?
| Hospitals, Low-Volume | 1 | 2019 | 27 | 0.170 |
Why?
| Electrocardiography, Ambulatory | 1 | 2019 | 58 | 0.170 |
Why?
| Antibodies, Monoclonal | 6 | 2008 | 1306 | 0.170 |
Why?
| Comparative Effectiveness Research | 1 | 2020 | 142 | 0.170 |
Why?
| Atrioventricular Block | 1 | 2019 | 35 | 0.170 |
Why?
| Popliteal Artery | 2 | 2009 | 63 | 0.170 |
Why?
| Anatomic Landmarks | 1 | 2019 | 28 | 0.170 |
Why?
| Cardiopulmonary Bypass | 1 | 2020 | 213 | 0.170 |
Why?
| Heart Valves | 1 | 2019 | 46 | 0.170 |
Why?
| Patient-Specific Modeling | 1 | 2019 | 37 | 0.170 |
Why?
| Magnetic Resonance Imaging | 2 | 2007 | 3264 | 0.170 |
Why?
| Hospital Costs | 1 | 2019 | 114 | 0.170 |
Why?
| Treatment Failure | 3 | 2009 | 348 | 0.170 |
Why?
| Length of Stay | 3 | 2020 | 1077 | 0.170 |
Why?
| Young Adult | 6 | 2021 | 11094 | 0.160 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2018 | 93 | 0.160 |
Why?
| Angioplasty, Balloon | 2 | 2011 | 92 | 0.160 |
Why?
| Bioprosthesis | 1 | 2018 | 37 | 0.160 |
Why?
| Software | 2 | 2016 | 631 | 0.160 |
Why?
| Models, Organizational | 2 | 2019 | 144 | 0.160 |
Why?
| Heart Block | 1 | 2018 | 41 | 0.160 |
Why?
| Diagnostic Errors | 2 | 2010 | 171 | 0.160 |
Why?
| Risk | 3 | 2019 | 890 | 0.160 |
Why?
| Proportional Hazards Models | 3 | 2019 | 1184 | 0.150 |
Why?
| Coronary Circulation | 2 | 2007 | 121 | 0.150 |
Why?
| Intention to Treat Analysis | 2 | 2017 | 72 | 0.150 |
Why?
| Disease Management | 2 | 2021 | 591 | 0.150 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 228 | 0.150 |
Why?
| Research Report | 1 | 2017 | 83 | 0.150 |
Why?
| France | 1 | 2016 | 38 | 0.150 |
Why?
| Single-Blind Method | 2 | 2017 | 275 | 0.140 |
Why?
| Personal Satisfaction | 1 | 2018 | 188 | 0.140 |
Why?
| Patient Safety | 2 | 2019 | 302 | 0.140 |
Why?
| Radiologic Health | 1 | 2015 | 5 | 0.140 |
Why?
| Atrial Pressure | 1 | 2015 | 5 | 0.140 |
Why?
| Tachycardia, Ventricular | 1 | 2018 | 174 | 0.140 |
Why?
| Atrial Function, Right | 1 | 2015 | 15 | 0.140 |
Why?
| Valsalva Maneuver | 1 | 2015 | 12 | 0.140 |
Why?
| Netherlands | 1 | 2015 | 74 | 0.140 |
Why?
| Radiation Exposure | 1 | 2016 | 52 | 0.140 |
Why?
| Movement | 2 | 2009 | 257 | 0.130 |
Why?
| Adolescent | 6 | 2021 | 18948 | 0.130 |
Why?
| Heart Rate | 2 | 2011 | 756 | 0.130 |
Why?
| Pulmonary Wedge Pressure | 1 | 2015 | 76 | 0.130 |
Why?
| Area Under Curve | 1 | 2015 | 303 | 0.130 |
Why?
| Intersectoral Collaboration | 1 | 2015 | 61 | 0.130 |
Why?
| Education, Medical, Graduate | 1 | 2019 | 432 | 0.130 |
Why?
| Patient Care Team | 1 | 2019 | 520 | 0.120 |
Why?
| Clinical Protocols | 1 | 2015 | 248 | 0.120 |
Why?
| Four-Dimensional Computed Tomography | 1 | 2014 | 27 | 0.120 |
Why?
| Health Services Accessibility | 1 | 2020 | 813 | 0.120 |
Why?
| Cardiac Catheters | 1 | 2013 | 17 | 0.120 |
Why?
| Atrial Septum | 1 | 2013 | 4 | 0.120 |
Why?
| ROC Curve | 1 | 2015 | 494 | 0.120 |
Why?
| Kidney Failure, Chronic | 1 | 2019 | 519 | 0.120 |
Why?
| Punctures | 1 | 2013 | 39 | 0.120 |
Why?
| X-Rays | 2 | 2010 | 28 | 0.120 |
Why?
| Ultrasonography | 2 | 2008 | 740 | 0.120 |
Why?
| Societies | 1 | 2013 | 42 | 0.110 |
Why?
| Global Health | 1 | 2016 | 352 | 0.110 |
Why?
| Propensity Score | 3 | 2019 | 253 | 0.110 |
Why?
| Femoral Artery | 2 | 2013 | 182 | 0.110 |
Why?
| Hospitals | 1 | 2017 | 633 | 0.110 |
Why?
| United States Food and Drug Administration | 1 | 2013 | 186 | 0.110 |
Why?
| Blood Pressure | 2 | 2011 | 1713 | 0.110 |
Why?
| Forecasting | 2 | 2016 | 372 | 0.110 |
Why?
| Cardiovascular Diseases | 1 | 2004 | 1859 | 0.100 |
Why?
| Models, Statistical | 1 | 2016 | 651 | 0.100 |
Why?
| Blood Vessel Prosthesis Implantation | 2 | 2004 | 187 | 0.100 |
Why?
| Research Design | 1 | 2018 | 1002 | 0.100 |
Why?
| Quality Improvement | 2 | 2019 | 1004 | 0.100 |
Why?
| Europe | 2 | 2009 | 369 | 0.100 |
Why?
| Electrocardiography | 2 | 2014 | 620 | 0.100 |
Why?
| Stress, Mechanical | 2 | 2003 | 440 | 0.100 |
Why?
| Automation, Laboratory | 1 | 2010 | 8 | 0.090 |
Why?
| Radiology, Interventional | 1 | 2010 | 30 | 0.090 |
Why?
| Data Collection | 1 | 2013 | 667 | 0.090 |
Why?
| Mitral Valve Prolapse | 1 | 2009 | 8 | 0.090 |
Why?
| Heart | 1 | 2014 | 649 | 0.090 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 34 | 0.090 |
Why?
| Hospitals, Veterans | 1 | 2011 | 260 | 0.090 |
Why?
| Cause of Death | 3 | 2018 | 389 | 0.090 |
Why?
| Artifacts | 2 | 2009 | 130 | 0.090 |
Why?
| Cardiovascular Surgical Procedures | 1 | 2009 | 38 | 0.090 |
Why?
| Patient Reported Outcome Measures | 2 | 2021 | 258 | 0.080 |
Why?
| Peripheral Vascular Diseases | 1 | 2009 | 102 | 0.080 |
Why?
| Equipment Failure Analysis | 1 | 2009 | 142 | 0.080 |
Why?
| Artificial Intelligence | 2 | 2010 | 146 | 0.080 |
Why?
| Prevalence | 2 | 2018 | 2442 | 0.080 |
Why?
| Nose | 1 | 2008 | 58 | 0.080 |
Why?
| Infant, Newborn | 1 | 2019 | 5430 | 0.080 |
Why?
| Ticlopidine | 1 | 2008 | 71 | 0.080 |
Why?
| Robotics | 1 | 2009 | 87 | 0.080 |
Why?
| Heart Failure | 2 | 2018 | 2114 | 0.080 |
Why?
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2005 | 22 | 0.080 |
Why?
| Endpoint Determination | 1 | 2008 | 69 | 0.080 |
Why?
| Phantoms, Imaging | 2 | 2010 | 154 | 0.080 |
Why?
| Linear Models | 1 | 2010 | 854 | 0.080 |
Why?
| Leg | 1 | 2009 | 249 | 0.080 |
Why?
| Motion | 2 | 2010 | 96 | 0.080 |
Why?
| Wakefulness | 1 | 2008 | 141 | 0.080 |
Why?
| Cardiac Tamponade | 1 | 2007 | 16 | 0.080 |
Why?
| Sirolimus | 1 | 2009 | 198 | 0.080 |
Why?
| Injections | 1 | 2007 | 171 | 0.070 |
Why?
| Quality Indicators, Health Care | 2 | 2019 | 315 | 0.070 |
Why?
| Thoracotomy | 1 | 2006 | 86 | 0.070 |
Why?
| Natriuretic Peptide, Brain | 1 | 2006 | 109 | 0.070 |
Why?
| Age Factors | 2 | 2020 | 3114 | 0.070 |
Why?
| Double-Blind Method | 2 | 2008 | 1711 | 0.070 |
Why?
| Pulmonary Artery | 1 | 2011 | 1097 | 0.070 |
Why?
| Muramic Acids | 1 | 2004 | 1 | 0.070 |
Why?
| Acetylmuramyl-Alanyl-Isoglutamine | 1 | 2004 | 14 | 0.070 |
Why?
| Peptidoglycan | 1 | 2004 | 28 | 0.060 |
Why?
| Ions | 1 | 2004 | 64 | 0.060 |
Why?
| Cell Wall | 1 | 2004 | 53 | 0.060 |
Why?
| Feasibility Studies | 1 | 2007 | 780 | 0.060 |
Why?
| Open Reading Frames | 1 | 2004 | 121 | 0.060 |
Why?
| Whole-Body Irradiation | 1 | 2004 | 72 | 0.060 |
Why?
| Probability | 1 | 2005 | 316 | 0.060 |
Why?
| Genome, Bacterial | 1 | 2004 | 111 | 0.060 |
Why?
| Quality of Life | 3 | 2021 | 2457 | 0.060 |
Why?
| Informed Consent | 1 | 2005 | 166 | 0.060 |
Why?
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2004 | 42 | 0.060 |
Why?
| Shear Strength | 1 | 2003 | 58 | 0.060 |
Why?
| Cloning, Molecular | 1 | 2004 | 551 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 884 | 0.060 |
Why?
| Thrombophilia | 1 | 2004 | 68 | 0.060 |
Why?
| Thrombocytopenia | 1 | 2005 | 188 | 0.060 |
Why?
| Diagnosis, Differential | 1 | 2007 | 1423 | 0.060 |
Why?
| Catheters | 1 | 2023 | 65 | 0.060 |
Why?
| Patient Care Planning | 1 | 2003 | 143 | 0.060 |
Why?
| Diabetes Complications | 1 | 2005 | 226 | 0.060 |
Why?
| Elasticity | 1 | 2003 | 192 | 0.050 |
Why?
| Numbers Needed To Treat | 1 | 2021 | 8 | 0.050 |
Why?
| Japan | 1 | 2022 | 108 | 0.050 |
Why?
| Creatinine | 1 | 2003 | 510 | 0.050 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2009 | 2127 | 0.050 |
Why?
| Bayes Theorem | 1 | 2023 | 363 | 0.050 |
Why?
| Curriculum | 1 | 2008 | 925 | 0.050 |
Why?
| Patient-Centered Care | 1 | 2006 | 513 | 0.050 |
Why?
| Acute Disease | 1 | 2003 | 984 | 0.050 |
Why?
| Drug Therapy, Combination | 2 | 2017 | 988 | 0.050 |
Why?
| Child | 2 | 2012 | 19561 | 0.050 |
Why?
| Patient Discharge | 2 | 2004 | 842 | 0.050 |
Why?
| Base Sequence | 1 | 2004 | 2186 | 0.050 |
Why?
| Florida | 1 | 2020 | 77 | 0.050 |
Why?
| Escherichia coli | 1 | 2004 | 767 | 0.050 |
Why?
| Computational Biology | 1 | 2004 | 601 | 0.050 |
Why?
| Syndrome | 1 | 2021 | 363 | 0.050 |
Why?
| Population Density | 1 | 2020 | 99 | 0.050 |
Why?
| Norepinephrine | 1 | 2001 | 214 | 0.050 |
Why?
| Epinephrine | 1 | 2001 | 166 | 0.040 |
Why?
| Molecular Sequence Data | 1 | 2004 | 2933 | 0.040 |
Why?
| Travel | 1 | 2020 | 124 | 0.040 |
Why?
| Cardiac Care Facilities | 1 | 2019 | 15 | 0.040 |
Why?
| Cost Savings | 1 | 2019 | 86 | 0.040 |
Why?
| Decision Making | 1 | 2006 | 840 | 0.040 |
Why?
| Credentialing | 1 | 2019 | 12 | 0.040 |
Why?
| Cardiac Imaging Techniques | 1 | 2019 | 21 | 0.040 |
Why?
| Health Care Surveys | 1 | 2021 | 564 | 0.040 |
Why?
| Terminology as Topic | 1 | 2020 | 217 | 0.040 |
Why?
| Trauma Severity Indices | 1 | 2019 | 128 | 0.040 |
Why?
| Adrenergic beta-Antagonists | 1 | 2001 | 334 | 0.040 |
Why?
| Models, Econometric | 1 | 2018 | 34 | 0.040 |
Why?
| Insurance, Health, Reimbursement | 1 | 2019 | 93 | 0.040 |
Why?
| Renin-Angiotensin System | 1 | 2018 | 83 | 0.040 |
Why?
| Residence Characteristics | 1 | 2020 | 313 | 0.040 |
Why?
| Workload | 1 | 2019 | 132 | 0.040 |
Why?
| Child, Preschool | 1 | 2012 | 9755 | 0.040 |
Why?
| Risk Management | 1 | 2018 | 94 | 0.040 |
Why?
| Inpatients | 2 | 2016 | 402 | 0.040 |
Why?
| Markov Chains | 1 | 2018 | 130 | 0.040 |
Why?
| Reference Values | 1 | 2019 | 789 | 0.040 |
Why?
| United Kingdom | 1 | 2018 | 260 | 0.040 |
Why?
| Intraoperative Complications | 1 | 2018 | 132 | 0.040 |
Why?
| Altitude | 1 | 2001 | 425 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2019 | 362 | 0.040 |
Why?
| Mortality | 1 | 2018 | 317 | 0.040 |
Why?
| Biomarkers | 1 | 2006 | 3662 | 0.030 |
Why?
| Renal Dialysis | 1 | 2019 | 395 | 0.030 |
Why?
| Congresses as Topic | 1 | 2016 | 208 | 0.030 |
Why?
| Survival Analysis | 1 | 2018 | 1325 | 0.030 |
Why?
| Models, Theoretical | 1 | 2019 | 574 | 0.030 |
Why?
| Medicaid | 1 | 2018 | 416 | 0.030 |
Why?
| Spatio-Temporal Analysis | 1 | 2014 | 30 | 0.030 |
Why?
| Comorbidity | 1 | 2019 | 1600 | 0.030 |
Why?
| Venous Thromboembolism | 1 | 2017 | 239 | 0.030 |
Why?
| Radiation | 1 | 2013 | 27 | 0.030 |
Why?
| Logistic Models | 1 | 2018 | 1995 | 0.030 |
Why?
| Constriction, Pathologic | 1 | 2011 | 212 | 0.020 |
Why?
| Combined Modality Therapy | 2 | 2005 | 1174 | 0.020 |
Why?
| Torsion, Mechanical | 1 | 2009 | 7 | 0.020 |
Why?
| Exercise | 1 | 2001 | 1743 | 0.020 |
Why?
| Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 119 | 0.020 |
Why?
| Patient Satisfaction | 1 | 2013 | 632 | 0.020 |
Why?
| Calibration | 1 | 2009 | 140 | 0.020 |
Why?
| Posture | 1 | 2009 | 168 | 0.020 |
Why?
| Radiography | 1 | 2010 | 888 | 0.020 |
Why?
| Myocardial Ischemia | 1 | 2008 | 267 | 0.020 |
Why?
| Biomechanical Phenomena | 1 | 2009 | 705 | 0.020 |
Why?
| Vascular Surgical Procedures | 1 | 2009 | 277 | 0.020 |
Why?
| Platelet Count | 1 | 2005 | 85 | 0.020 |
Why?
| Age Distribution | 1 | 2005 | 376 | 0.020 |
Why?
| Sex Distribution | 1 | 2005 | 370 | 0.020 |
Why?
| Patient Admission | 1 | 2004 | 195 | 0.010 |
Why?
| Odds Ratio | 1 | 2005 | 1043 | 0.010 |
Why?
| Myocardial Reperfusion | 1 | 2002 | 62 | 0.010 |
Why?
| Heparin | 1 | 2003 | 240 | 0.010 |
Why?
| Cross-Over Studies | 1 | 2003 | 469 | 0.010 |
Why?
| Postoperative Care | 1 | 2003 | 245 | 0.010 |
Why?
| Prazosin | 1 | 2001 | 24 | 0.010 |
Why?
| Adrenergic alpha-Agonists | 1 | 2001 | 31 | 0.010 |
Why?
| Adrenergic alpha-Antagonists | 1 | 2001 | 31 | 0.010 |
Why?
| Phenylephrine | 1 | 2001 | 85 | 0.010 |
Why?
| Health Care Costs | 1 | 2003 | 414 | 0.010 |
Why?
| Oxygen Consumption | 1 | 2001 | 613 | 0.010 |
Why?
|
|
Carroll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|